Newcleo

London, United Kingdom Founded: 2021 • Age: 5 yrs Listed
Advanced nuclear reactors are designed, built, and operated by Newcleo.

About Newcleo

Newcleo is a publicly listed company based in London (United Kingdom) founded in 2021 by Luciano Cinotti, Elisabeth Rizzotti, and Stefano Buono. Advanced nuclear reactors are designed, built, and operated by Newcleo. Newcleo has raised $842.85 million across 7 funding rounds from investors including Gov.uk, Danieli and Exor. The company has 608 employees. Newcleo has completed 4 acquisitions, including Fucina Italia, Gruppe Rutschi and Hydromine. Newcleo was last valued at $2.83 billion in May 2026. Its chief executive, as recorded, is Stefano Buono. Its website newcleo.com draws about 23 thousand monthly visits. Its focus areas include Energy, Nuclear Energy, Hardware Developer and Reactors. Its legal entity is NEWCLEO LTD.

Company details

Newcleo was founded in 2021 and is headquartered in London, United Kingdom. Operations are centered in the nuclear energy sector, where Generation IV small modular lead-cooled fast reactors are developed. Innovative reactor designs and circular nuclear energy solutions are pursued to support industry advancements. Engineering and technology integration are emphasized across design, construction, and operational phases.

  • Headquarters London, United Kingdom
  • Employees 608
  • Founders Luciano Cinotti, Elisabeth Rizzotti, Stefano Buono
  • Stage Public
  • Sectors
    Energy & Utilities
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website newcleo.com
  • Social LinkedIn X
  • Legal Name Newhold Investment Corp Iii
Key Metrics
  • Annual Revenue
    $11.38 M (USD)
    as on Dec 31, 2023
  • Net Profit
    -$71.65 M (USD)
    -219
    as on Dec 31, 2023
  • EBITDA
    -$71.4 M (USD)
    -196
    as on Dec 31, 2023
  • Total Equity Funding
    $842.85M (USD)

    in 7 rounds

  • Latest Funding Round
    $85M (USD), Series B

    Feb 2026

  • Investors
    Gov.uk

    & 34 more

  • Employee Count
    608
  • Investments & Acquisitions

Funding Insights of Newcleo

Newcleo has successfully raised a total of $842.85M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $85 million completed in February 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $842.85M
  • Total Rounds 7
  • Last Round Series B β€” $85M
  • First Round $153,300

    (Apr 2021)

  • Investors Count 35

All 7 funding rounds of Newcleo with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2026$85MSeries B––
Sep 2024$151MSeries B–Inarcassa
–
May 2024$93.82MSeries B––
–
Mar 2023Series B––
–
Jun 2022$321.96MSeries B––
Aug 2021$118MSeries B–Exor, LIFTT
–
Apr 2021$153,300Seed––
–
Valuation history
DateValuationStage
Premium access

Full valuation and stage history of Newcleo

Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.

  • All valuation points
  • Stage changes
  • Dates
  • Exports

Verified entity values are shown only after access is granted.

Last known valuation $2.83B (May 2026). 35 investors in total: 35 institutional.

Investors in Newcleo

Newcleo has secured backing from 35 investors, including institutional and venture fund investors. Prominent investors backing the company include Gov.uk, Danieli and Exor.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
progressttfund.it
Venture capital firm focused on multiple sectors
2019liftt.comTorino, Italy
A network of business angels investing in innovative companies is operated.
clubdeglinvestitori.itTurin, Italy
Venture capital investments are managed by Indaco in Italy.
2016indacosgr.comMilan, Italy
Early stage venture capital and co-investment platform
3lbseed.comTurin, Italy
elysiacapital.com
Venture capital fund focused on early-stage healthcare, fintech, deep tech, and multiple sectors
novacapital.euMilano, Italy
feelventure.vc
healthcap.eu
A Belgium-based private equity fund offering diversified investment platforms.
integra.fundBelgium
Premium access

Investor details for Newcleo

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Newcleo

86 people are tracked at Newcleo (34 in leadership, 4 in board & advisors, 48 in team); the tracked headcount is 608.

NameRoleGroup
Luciano Cinotti
Co-Founder & CSOLeadership
Elisabeth Rizzotti
Co-Founder & COOLeadership
Stefano Buono
Co-Founder & CEOLeadership
Andrew Murdoch
Managing DirectorLeadership
Ludovic Vandendriesche
Managing DirectorLeadership
Miroslav Sarissky
Managing DirectorLeadership
Cedric Barba
Managing DirectorLeadership
Andrea Barbensi
LFR Engineering DirectorLeadership
Luigi Sportiello
Head Of Information Technology OperationsLeadership
John Fenwick
Chief Information OfficerLeadership
Alberto De Min
Chief Business OfficerLeadership
Stéphane Chapelle
Integration Manager And Head Of Process UnitLeadership
Fabio Moretti
R&d Thermal Hydraulics, Head Of UnitLeadership
Massimo Marino
Managing Director, FranceLeadership
Viviana Lanzetti
Executive Assistant To Chief Executive OfficerLeadership
Cristiana Vieno
Deputy MD Italy And CFOLeadership
Silvio Colloca
Head Of Information SecurityLeadership
Kirubashankar Manohar
Head Of Global IT Support & OperationsLeadership
Venkat Chenna
Head Of DataLeadership
James Bowyer
Project DirectorLeadership

66 more people are available in the full profile.

Premium access

Complete people profiles for Newcleo

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Newcleo

Newcleo is a publicly listed company on the NASDAQ with ticker symbol NWCL in USA, operating in the Producer manufacturing sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date22 Sep 2026
  • Listed onNASDAQ: NWCL
  • Listed entitynewcleo plc
  • Exchange sectorProducer manufacturing
  • ISINGB00BX835R35
  • Share price$10.54 · 2026-05-11
  • Market capitalisation$291.0M
  • Price to earnings59.2
  • EPS (diluted, trailing year)$0.18
  • Volume (last session)44,965
  • Analyst consensusNo rating

Investments & Acquisitions by Newcleo

Newcleo has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Fucina Italia, Gruppe Rutschi and Hydromine.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Centrifugal pumps for nuclear and industrial uses are manufactured.
grupperutschi.comIllzach, France1946Aug 2023β€’β€’β€’β€’
Provider of steel machinery, cranes & lifting equipment design, manufacturing, and assembly services
fucinaitalia.itPiombino, Italy2017Jun 2023β€’β€’β€’β€’
Installation, electrical, and construction design services are provided.
srs.itRomana, Italy1976Jun 2023β€’β€’β€’β€’
Hydro power project developer
hydromineinc.comNew York, United States2014Sep 2021β€’β€’β€’β€’
Premium access

Complete acquisition details for Newcleo

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Newcleo

9 dated milestones of Newcleo across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Newcleo is founded.
  2. Funding First funding round of $153K.
  3. Acquisition Acquires Hydromine.
  4. Acquisition Acquires SRS Italy.
  5. Acquisition Acquires Fucina Italia.
  6. Acquisition Acquires Gruppe Rutschi.
  7. Milestone Reaches Unicorn status.
  8. Funding Latest funding round, Series B, of $85.0M.
  9. IPO Lists on the stock exchange (IPO).

Web traffic of Newcleo

The website of Newcleo (newcleo.com) receives about 23K visits a month.

  • Monthly visits
    23K

    ▲ 31.3% vs previous month

Similar websites

Websites whose visitors overlap most with Newcleo. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
nuklearforum.ch
100%
#1,803,545View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Newcleo

Premium access

Complete news archive for Newcleo

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Newcleo

Newcleo was founded in 2021.

Newcleo is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

Stefano Buono is the CEO of Newcleo, as recorded in our data. They have also founded this company.

Newcleo is a funded company, having raised a total of $842.85M across 7 funding rounds to date. The company's 1st funding round was a Seed of $153.3K, raised on Apr 2021.

Newcleo has 608 employees.

Annual revenue of Newcleo is $11.38M as on Dec 31, 2023.

Newcleo was founded in 2021 and is headquartered in London, United Kingdom. Operations are centered in the nuclear energy sector, where Generation IV small modular lead-cooled fast reactors are developed. Innovative reactor designs and circular nuclear energy solutions are pursued to support industry advancements. Engineering and technology integration are emphasized across design, construction, and operational phases.

Yes, Newcleo is publicly traded on NASDAQ under the ticker symbol NWCL.

Newcleo has made 4 acquisitions, including Fucina Italia, Gruppe Rutschi, and Hydromine.

Newcleo has 35 investors. Key investors include Gov.uk, Danieli, Exor, NewHold Enterprises, and REYL Group.

The valuation of Newcleo is $2.83B as of May 2026.

Newcleo operates through Newcleo Ltd.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available